Assign a sentiment category to this news related to finance.
Options: positive, negative
Text: After the reporting period , BioTie North American licensing partner Somaxon Pharmaceuticals announced positive results with nalmefene in a pilot Phase 2 clinical trial for smoking cessation .
user
positive
assistant